EcoDrugPlus

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSCDRG00005006240
Gene Symbol: GUCY1A1
3 Cross references
203 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSCDRG00005020590
Gene Symbol: GUCY1A2
1 Cross references
203 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSCDRG00005006271
Gene Symbol: GUCY1B1
3 Cross references
211 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class A Member 1

Ensembl ID : ENSCDRG00005005574
Gene Symbol: HSP90AA1
1 Cross references
263 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class B Member 1

Ensembl ID : ENSCDRG00005016031
Gene Symbol: HSP90AB1
3 Cross references
198 Possible Orthologues:

High Mobility Group Box 1

Ensembl ID : ENSCDRG00005005045
Gene Symbol: HMGB1
3 Cross references
252 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSCDRG00005016405
Gene Symbol: HRH1
3 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSCDRG00005004042
Gene Symbol: HRH2
3 Cross references
249 Possible Orthologues:

Histamine Receptor H3

Ensembl ID : ENSCDRG00005005077
Gene Symbol: HRH3
1 Cross references
117 Possible Orthologues:

Histamine Receptor H4

Ensembl ID : ENSCDRG00005017544
Gene Symbol: HRH4
3 Cross references
104 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSCDRG00005020541
Gene Symbol: HDAC1
3 Cross references
278 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSCDRG00005015046
Gene Symbol: HDAC10
3 Cross references
181 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).